Derivation of NEM2 affected human embryonic stem cell line Genea078

Stem Cell Res. 2016 Mar;16(2):427-9. doi: 10.1016/j.scr.2016.02.004. Epub 2016 Feb 3.

Abstract

The Genea078 human embryonic stem cell line was derived from a donated, fully commercially consented ART blastocyst, carrying compound heterozygous mutations in the NEB gene, exon 55 deletion & c.15110dupA, indicative of Nemaline Myopathy Type 2 (NEM2). Following ICM outgrowth on inactivated human feeders, karyotype was confirmed as 46, XX and STR analysis demonstrated a female Allele pattern. The hESC line had pluripotent cell morphology, 76% of cells expressed Nanog, 93% Oct4, 67% Tra1-60 and 97% SSEA4 and gave a Pluritest Pluripotency score of 42.18, Novelty of 1.37. The cell line was negative for Mycoplasma and visible contamination.

MeSH terms

  • Alleles
  • Blastocyst / cytology*
  • Cells, Cultured
  • Cellular Reprogramming
  • Comparative Genomic Hybridization
  • Exons
  • Female
  • Flow Cytometry
  • Heterozygote
  • Human Embryonic Stem Cells / cytology*
  • Human Embryonic Stem Cells / metabolism
  • Humans
  • Karyotype
  • Microscopy, Fluorescence
  • Muscle Proteins / genetics
  • Myopathies, Nemaline / metabolism
  • Myopathies, Nemaline / pathology*
  • Transcription Factors / genetics
  • Transcription Factors / metabolism

Substances

  • Muscle Proteins
  • Transcription Factors
  • nebulin

Supplementary concepts

  • Nemaline Myopathy 2